Evidence map›Paper›PMID 30632098›Full record

ReviewImmunologic research2018

From the bluetongue vaccination campaigns in sheep to overimmunization and ovine ASIA syndrome.

J Asín, M Pérez, P Pinczowski, M Gimeno, L Luján

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J AsínDepartment of Animal Pathology, Veterinary Faculty, University of Zaragoza, 177 Miguel Servet street, 50013, Zaragoza, Spain.
M PérezDepartment of Anatomy, Embryology and Genetics, Veterinary Faculty, University of Zaragoza, 177 Miguel Servet street, 50013, Zaragoza, Spain.
P PinczowskiDepartment of Animal Pathology, Veterinary Faculty, University of Zaragoza, 177 Miguel Servet street, 50013, Zaragoza, Spain.
M GimenoDepartment of Animal Pathology, Veterinary Faculty, University of Zaragoza, 177 Miguel Servet street, 50013, Zaragoza, Spain.
L LujánDepartment of Animal Pathology, Veterinary Faculty, University of Zaragoza, 177 Miguel Servet street, 50013, Zaragoza, Spain. Lluis.Lujan@unizar.es.
Universidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of vaccines has proven to be very effective in controlling and eradicating infectious diseases, both in veterinary and human medicine; however, vaccines can be also the source of an array of problems caused by procedures such as overimmunization. Bluetongue, an orbiviral disease that affects ruminants, is best controlled by the use of inactivated vaccines. During the last years of the past decade, these vaccines were applied all over Europe to control the spreading of the disease, a goal that was accomplished; however, at the same time, several adverse effects related to the vaccination were reported. Especially in sheep, this vaccination campaign brought out a new cachectic and neurologic disease with harmful consequences for the ovine industry. This disease is now recognized as the ovine version of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) and poses an immense challenge in veterinary medicine, immunology, and vaccinology.

Indexed as

AnimalsBluetongueBluetongue virusEuropeImmunization ProgramsSheepSheep DiseasesSyndromeVaccinationViral VaccinesViral VaccinesAluminum-based adjuvantBluetongueOverimmunizationOvine ASIA syndromeSheep

Identifiers

PMID30632098
OpenAlexW2908812550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.